Siemens Healthineers Announces FDA Clearance of Cios Spin Mobile 3D C-Arm
Malvern, PA | Nov 06, 2018
Siemens Healthineers has announced the Food and Drug Administration (FDA) clearance of the Cios Spin, a new mobile C-arm that delivers precise 3D images for intraoperative quality assurance. By enabling surgeons to perform intraoperative corrections based on 3D images and confirm their results, the Cios Spin can help surgeons work with greater precision, transform the delivery of patient care, and achieve optimal treatment results.
Capable of integrating seamlessly into the clinical routine, the Cios Spin provides 3D computed tomography (CT)-like imaging for orthopedic, trauma and spine surgery. These 3D images can help reduce the rate of revisions with intraoperative evaluation as well as the need for post-operative CT. Cios Spin provides versatility to support both 2D and 3D imaging for a wide variety of procedures, including vascular imaging. The system’s NaviLink 3D digital navigation provides easy-to-use connectivity to surgical navigation.
Cios Spin is equipped with state-of-the-art flat panel detector technology and is available with a range of optional software packages. The Easy 3D package ensures fast, efficient setup, and image acquisition. The Screw Scout package enables system software to recognize and automatically label screws in a 3D X-ray image, saving time and effort for the surgeon.
The system’s high generator power addresses the challenge of imaging large patients and dense anatomy to enable precise clinical evaluation of images. And the Cios Spin is the first commercially available mobile C-arm with an antimicrobial coating for comprehensive infection control.
“Siemens Healthineers is proud to offer the Cios Spin, a dynamic new mobile 3D C-arm that illustrates our expertise in mobile X-ray imaging,” said Robert Dewey, Vice President of Surgical Solutions at Siemens Healthineers North America. “This system will help our customers improve the quality of patient care using precision medicine as well as reduce the additional costs imposed by revision surgery.”
Contact for journalists
Jeff Bell
Phone: (484) 868-8346; Email: jeffrey.t.bell@siemens-healthineers.com
Siemens Healthineers enables healthcare providers worldwide to increase value by empowering them on their journey towards expanding precision medicine, transforming care delivery, improving patient experience and digitalizing healthcare. A leader in medical technology, Siemens Healthineers is constantly innovating its portfolio of products and services in its core areas of diagnostic and therapeutic imaging and in laboratory diagnostics and molecular medicine. Siemens Healthineers is also actively developing its digital health services and enterprise services. In fiscal 2017, which ended on September 30, 2017, Siemens Healthineers generated revenue of €13.7 billion and adjusted profit of €2.5 billion and has about 48,000 employees worldwide. Further information is available at www.siemens-healthineers.com.